HIGHLIGHTS
- who: Emily N. Reinke and collaborators from the Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, United States of America, Department of Medicine, University of Illinois at Chicago have published the article: Translational Regulation of GPx-1 and GPx-4 by the mTOR Pathway, in the Journal: PLOS ONE | www.plosone.org of February/10,/2014
- how: Based on the observation that GPx-1 activity could be enhanced by tyrosine phosphorylation and inhibited using the Bcr-Abl small molecule inhibitor imatinib the authors explored the possibility that patients being treated for chronic myelogenous . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.